Current management of ophthalmic zoster.
- 1 August 1990
- journal article
- review article
- Vol. 18 (3) , 273-9
Abstract
Most ophthalmic zoster occurs in healthy people and ocular complications occur in 50%. The mainstay of ocular therapy is topical steroid, but careful follow-up and withdrawal are essential. The place of systemic steroid therapy and acyclovir in immunocompetent patients with zoster is uncertain.This publication has 0 references indexed in Scilit: